• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Direct-from-Blood Detection of Pathogens: a Review of Technology and Challenges.直接从血液中检测病原体:技术与挑战综述。
J Clin Microbiol. 2023 Jul 20;61(7):e0023121. doi: 10.1128/jcm.00231-21. Epub 2023 May 24.
2
Direct Detection of Pathogens in Bloodstream During Sepsis: Are We There Yet?脓毒症期间血流中病原体的直接检测:我们做到了吗?
J Appl Lab Med. 2019 Jan;3(4):631-642. doi: 10.1373/jalm.2018.028274. Epub 2018 Nov 30.
3
Next-generation sequencing diagnostics of bacteremia in septic patients.脓毒症患者菌血症的新一代测序诊断
Genome Med. 2016 Jul 1;8(1):73. doi: 10.1186/s13073-016-0326-8.
4
Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing.采用下一代测序技术对免疫功能低下血流感染患儿进行病原体的全面检测。
Sci Rep. 2018 Feb 28;8(1):3784. doi: 10.1038/s41598-018-22133-y.
5
Next-generation sequencing diagnostics of bacteremia in sepsis (Next GeneSiS-Trial): Study protocol of a prospective, observational, noninterventional, multicenter, clinical trial.脓毒症中菌血症的下一代测序诊断(Next GeneSiS试验):一项前瞻性、观察性、非干预性、多中心临床试验的研究方案
Medicine (Baltimore). 2018 Feb;97(6):e9868. doi: 10.1097/MD.0000000000009868.
6
Molecular and biomarker-based diagnostics in early sepsis: current challenges and future perspectives.早期脓毒症的分子和生物标志物诊断:当前的挑战和未来的展望。
Expert Rev Mol Diagn. 2019 Dec;19(12):1069-1078. doi: 10.1080/14737159.2020.1680285. Epub 2019 Oct 15.
7
Comparative of clinical performance between next-generation sequencing and standard blood culture diagnostic method in patients suffering from sepsis.比较脓毒症患者下一代测序与标准血培养诊断方法的临床性能。
J Microbiol Immunol Infect. 2022 Oct;55(5):845-852. doi: 10.1016/j.jmii.2022.07.011. Epub 2022 Aug 7.
8
Molecular methods for septicemia diagnosis.败血症诊断的分子方法。
Enferm Infecc Microbiol Clin. 2017 Nov;35(9):586-592. doi: 10.1016/j.eimc.2017.03.002. Epub 2017 Apr 17.
9
Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units.宏基因组下一代测序在重症监护病房脓毒症患者病因诊断中的应用。
Microbiol Spectr. 2022 Aug 31;10(4):e0074622. doi: 10.1128/spectrum.00746-22. Epub 2022 Jul 21.
10
Diagnostic accuracy of the BioFire FilmArray blood culture identification panel when used in critically ill patients with sepsis.严重脓毒症患者应用 FilmArray 血培养鉴定板的诊断准确性。
J Microbiol Methods. 2021 Oct;189:106303. doi: 10.1016/j.mimet.2021.106303. Epub 2021 Aug 17.

引用本文的文献

1
Electrochemical Aptamer-Based Biosensors for Sepsis Diagnosis: Recent Advances, Challenges, and Future Perspectives (2020-2025).用于脓毒症诊断的基于适配体的电化学生物传感器:最新进展、挑战及未来展望(2020 - 2025年)
Biosensors (Basel). 2025 Jun 20;15(7):402. doi: 10.3390/bios15070402.
2
Point of care sepsis diagnosis: Exploring microfluidic techniques for sample preparation, biomarker isolation, and detection.床旁脓毒症诊断:探索用于样品制备、生物标志物分离和检测的微流控技术。
Biomicrofluidics. 2025 Jul 1;19(4):041502. doi: 10.1063/5.0248096. eCollection 2025 Jul.
3
Evaluation of the Diagnostic Accuracy of the T2Resistance Panel (Research Use Only) in Patients With Possible Bacterial Bloodstream Infections.评估T2耐药检测板(仅供研究使用)对疑似细菌性血流感染患者的诊断准确性。
Ochsner J. 2025 Spring;25(1):24-33. doi: 10.31486/toj.24.0101.
4
Early Diagnosis of Bloodstream Infections Using Serum Metabolomic Analysis.利用血清代谢组学分析进行血流感染的早期诊断
Metabolites. 2024 Dec 6;14(12):685. doi: 10.3390/metabo14120685.
5
Effects of fermented L. on the profile of hematology, clinical chemistry, and circulatory CD4+/CD8+ in Sprague Dawley rats.发酵乳杆菌对 Sprague Dawley 大鼠血液学、临床化学和循环 CD4+/CD8+特征的影响。
Open Vet J. 2024 Sep;14(9):2475-2483. doi: 10.5455/OVJ.2024.v14.i9.36. Epub 2024 Sep 30.
6
Performance of the LifeScale automated rapid phenotypic antimicrobial susceptibility testing on Gram-negative rods directly from positive blood cultures.直接对来自阳性血培养物的革兰氏阴性杆菌进行LifeScale自动化快速表型抗菌药物敏感性测试的性能。
J Clin Microbiol. 2024 Dec 11;62(12):e0092224. doi: 10.1128/jcm.00922-24. Epub 2024 Oct 31.
7
Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report.开发和实施传染病分子诊断管理计划的方法:ASM 实验室实践小组委员会报告。
J Clin Microbiol. 2024 Nov 13;62(11):e0094124. doi: 10.1128/jcm.00941-24. Epub 2024 Oct 21.
8
Comparing NGS-Based identification of bloodstream infections to traditional culture methods for enhanced ICU care: a comprehensive study.基于 NGS 的血流感染鉴定与传统培养方法在 ICU 治疗中的比较:一项全面研究。
Front Cell Infect Microbiol. 2024 Sep 12;14:1454549. doi: 10.3389/fcimb.2024.1454549. eCollection 2024.
9
Etiological diagnostic performance of probe capture-based targeted next-generation sequencing in bloodstream infection.基于探针捕获的靶向二代测序技术在血流感染中的病因学诊断性能
J Thorac Dis. 2024 Apr 30;16(4):2539-2549. doi: 10.21037/jtd-24-400. Epub 2024 Apr 18.
10
The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department.急诊科抗菌药物管理的干预措施与挑战
Antibiotics (Basel). 2023 Oct 9;12(10):1522. doi: 10.3390/antibiotics12101522.

本文引用的文献

1
Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.医院获得性菌血症和真菌血症:比较 267 家医院的两种风险调整模型的预测因素和基准比较可行性评估。
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1317-1325. doi: 10.1017/ice.2022.211. Epub 2022 Sep 9.
2
The Human "Contaminome" and Understanding Infectious Disease.人类“污染物组”与传染病理解
N Engl J Med. 2022 Sep 8;387(10):943-946. doi: 10.1056/NEJMcibr2208625.
3
Association Between Time to Appropriate Antimicrobial Treatment and 30-day Mortality in Patients With Bloodstream Infections: A Retrospective Cohort Study.适当抗菌治疗时间与血流感染患者 30 天死亡率之间的关系:一项回顾性队列研究。
Clin Infect Dis. 2023 Feb 8;76(3):469-478. doi: 10.1093/cid/ciac727.
4
Pathogen Detection in Infective Endocarditis Using Targeted Metagenomics on Whole Blood and Plasma: a Prospective Pilot Study.使用全血和血浆靶向宏基因组学检测感染性心内膜炎病原体:一项前瞻性初步研究。
J Clin Microbiol. 2022 Sep 21;60(9):e0062122. doi: 10.1128/jcm.00621-22. Epub 2022 Aug 30.
5
Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital.揭示快速抗生素药敏测试系统在大型城市医院革兰氏阴性血培养中的性能。
J Clin Microbiol. 2022 Jun 15;60(6):e0009822. doi: 10.1128/jcm.00098-22. Epub 2022 May 24.
6
Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.诊断性血液培养管理对危重症儿童的影响:与培养率、抗生素使用和患者结局的关联:BRIGHT STAR 协作研究结果。
JAMA Pediatr. 2022 Jul 1;176(7):690-698. doi: 10.1001/jamapediatrics.2022.1024.
7
The Impact of Implementing the Virtuo Blood Culture System on the Characteristics and Management of Patients with Staphylococcus aureus Bacteremia.实施 Virtuo 血培养系统对金黄色葡萄球菌菌血症患者特征和管理的影响。
J Clin Microbiol. 2022 Apr 20;60(4):e0226121. doi: 10.1128/jcm.02261-21. Epub 2022 Mar 16.
8
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience.T2Dx 磁共振检测法在疑似血流感染患者中的作用:单中心真实世界经验。
BMC Infect Dis. 2022 Feb 1;22(1):113. doi: 10.1186/s12879-022-07096-w.
9
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
10
Accuracy and Impact on Patient Management of New Tools for Diagnosis of Sepsis: Experience with the T2 Magnetic Resonance Bacteria Panel.脓毒症诊断新工具的准确性及其对患者管理的影响:T2磁共振细菌检测板的经验
Pathogens. 2021 Sep 2;10(9):1132. doi: 10.3390/pathogens10091132.

直接从血液中检测病原体:技术与挑战综述。

Direct-from-Blood Detection of Pathogens: a Review of Technology and Challenges.

机构信息

Division of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, Michigan, USA.

出版信息

J Clin Microbiol. 2023 Jul 20;61(7):e0023121. doi: 10.1128/jcm.00231-21. Epub 2023 May 24.

DOI:10.1128/jcm.00231-21
PMID:37222587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10358183/
Abstract

Blood cultures have been the staple of clinical microbiology laboratories for well over half a century, but gaps remain in our ability to identify the causative agent in patients presenting with signs and symptoms of sepsis. Molecular technologies have revolutionized the clinical microbiology laboratory in many areas but have yet to present a viable alternative to blood cultures. There has been a recent surge of interest in utilizing novel approaches to address this challenge. In this minireview, I discuss whether molecular tools will finally give us the answers we need and the practical challenges of incorporating them into the diagnostic algorithm.

摘要

血液培养在临床微生物学实验室已经有半个多世纪的历史了,但在识别出现败血症症状和体征的患者的病原体方面,我们的能力仍存在差距。分子技术已经彻底改变了临床微生物学实验室的许多领域,但尚未提供一种可行的血液培养替代方法。最近,人们对利用新方法来解决这一挑战产生了浓厚的兴趣。在这篇简评中,我将讨论分子工具是否最终会为我们提供所需的答案,以及将它们纳入诊断算法的实际挑战。